Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015434
Filing Date
2025-06-03
Accepted
2025-06-03 17:33:09
Documents
1
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 form4-06032025_090644.html 4  
1 form4-06032025_090644.xml 4 4163
  Complete submission text file 0001415889-25-015434.txt   5642
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 3175 HANOVER STREET PALO ALTO CA 94304
Business Address
Kosacz Barbara (Reporting) CIK: 0001763316 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 251021097